WilliamEdwardBradyIIIMD

PubMed

• 28 citations
  Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study
  Warner K. Huh, William E. Brady, Paula M. Fracasso, Don S. Dizon, Matthew A. Powell, Bradley J. Monk, Charles A. Leath, Lisa M. Landrum, Edward J. Tanner, Erin K. Cran...> ;Gynecologic Oncology. 2020 Sep 1
• 1 citations
  Findings from Optometrists' Practices in Advising about Lifestyle Study.
  Michelle W. Sahli, Heather M. Ochs-Balcom, Suzen M. Moeller, William E. Brady, Timothy W Tolford, Amy E. Millen> ;Optometry and Vision Science. 2020 Aug 1
• 40 citations
  Left ventricular assist devices and their complications: A review for emergency clinicians
  Brit Long, Jennifer Robertson, Alex Koyfman, William E. Brady> ;The American Journal of Emergency Medicine. 2019 Aug 1
• 4 citations
  Do brain mets grow while you wait? A volumetric natural history assessment of brain metastases from time of diagnosis to gamma knife treatment.
  Robert J. Plunkett, Tara A. Barone, William E. Brady, Kristopher Attwood, Dheerendra Prasad> ;Journal of Clinical Neuroscience. 2019 Jul 22
• 50 citations
  An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting...
  Martin Gore, Allan Hackshaw, William E. Brady, Richard T. Penson, Richard J. Zaino, W. Glenn McCluggage, Raji Ganesan, Nafisa Wilkinson, Timothy J. Perren, Ana Montes,...> ;Gynecologic Oncology. 2019 Jun 1
• A single lead of concordant ST deviation in Left Bundle Branch Block.
  Brian Lin, Amal Mattu, William E. Brady, Jeffrey A. Tabas> ;Annals of Emergency Medicine. 2019 Apr 1
• 16 citations
  A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients.
  Wen Wee Ma, Hao Xie, Gerald J. Fetterly, Laura Pitzonka, Amy Whitworth, Charles LeVea, John Wilton, Krystin Mantione, Grace K. Dy, Patrick McKay Boland, Renuka Iyer, W...> ;American Journal of Clinical Oncology. 2019 Feb 1
• Elderly Man With Chest Pressure
  Eric Leroux, Christina Houser, Jeffrey A. Tabas, Amal Mattu, William E. Brady, Jonathan E. Davis> ;Annals of Emergency Medicine. 2018 Nov 1
• 10 citations
  A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cerv...
  Cecelia H. Boardman, William E. Brady, Don S. Dizon, Charles A. Kunos, Kathleen N. Moore, Kristine M. Zanotti, Cara Matthews, Jonathan A. Cosin, Carol Aghajanian, Paul...> ;Gynecologic Oncology. 2018 Nov 1
• 36 citations
  Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)
  Panagiotis A. Konstantinopoulos, William E. Brady, John H. Farley, Amy Armstrong, Denise Uyar, David M. Gershenson> ;Gynecologic Oncology. 2018 Jul 1
• 57 citations
  A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254).
  John K. Chan, William E. Brady, Bradley J. Monk, Jubilee Brown, Mark S. Shahin, Peter G. Rose, Jae Hoon Kim, Angeles Alvarez Secord, Joan L. Walker, David M. Gershenson> ;Gynecologic Oncology. 2015 May 1
• 17 citations
  Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
  Rachana Shah, Caihong Xia, Mark Krailo, James F. Amatruda, Suren G. Arul, Deborah F. Billmire, William E. Brady, Allan Covens, David M. Gershenson, Juliet Hale, Jean A...> ;Gynecologic Oncology. 2018 Aug 1
• 24 citations
  The HEART score: A guide to its application in the emergency department.
  William E. Brady, Katya de Souza> ;Turkish Journal of Emergency Medicine. 2018 Jun 1
• 7 citations
  Clinical trial methodology in rare gynecologic tumor research: Strategies for success.
  Jubilee Brown, R. Wendel Naumann, William E. Brady, Robert L. Coleman, Kathleen N. Moore, David M. Gershenson> ;Gynecologic Oncology. 2018 Jun 1
• 30 citations
  A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patien...
  Premal H. Thaker, William E. Brady, Kunle Odunsi, William H. Bradley, Kathleen N. Moore, Carolyn Y. Muller, Khursheed Anwer, Russell J. Schilder, Ronald D. Alvarez, Pa...> ;Gynecologic Oncology. 2017 Nov 1
• 54 citations
  An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum ther...
  Kate E. Oliver, William E. Brady, Michael J. Birrer, David M. Gershenson, Gini F. Fleming, Larry J. Copeland, Krishnansu S. Tewari, Peter A. Argenta, Robert S. Mannel,...> ;Gynecologic Oncology. 2017 Nov 1
• 15 citations
  A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Onco...
  Danielle A. Jandial, William E. Brady, Stephen B. Howell, Heather A. Lankes, Russell J. Schilder, Jan H. Beumer, Susan M. Christner, Sandra Strychor, Matthew A. Powell...> ;Gynecologic Oncology. 2017 May 1
• 27 citations
  Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy.
  Bradley J. Monk, Andrea Facciabene, William E. Brady, Carol Aghajanian, Paula M. Fracasso, Joan L. Walker, Heather A. Lankes, Kristi Manjarrez, Gwenn Danet-Desnoyers, ...> ;Clinical Cancer Research. 2017 Apr 15
• 10 citations
  A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia
  Elizabeth A. Griffiths, William E. Brady, Wei Tan, Carlos E. Vigil, James E. Thompson, Laurie A. Ford, Noelle M. Dickey, Heather L. Bashaw, Jill Sperrazza, Meir Wetzle...> ;Leukemia Research. 2016 Apr 1
• 19 citations
  Dietary Intake of Lutein and Diabetic Retinopathy in the Atherosclerosis Risk in Communities Study (ARIC).
  Michelle W. Sahli, Julie A. Mares, Kristin J. Meyers, Ronald Klein, William E. Brady, Barbara E.K. Klein, Heather M. Ochs-Balcom, Richard P. Donahue, Amy E. Millen> ;Ophthalmic Epidemiology. 2016 Mar 7
• The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study.
  Rocconi, R. P.,Lankes, H. A.,Brady, W. E.,Goodfellow, P. J.,Ramirez, N. C.,Alvarez, R. D.,Creasman, W.,Fernández, J. R.> ;Gynecol. Oncol.. 2015 Nov 26
• 87 citations
  Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative
  Farzana Pashankar, Juliet Hale, Ha Dang, Mark Krailo, William E. Brady, Carlos Rodriguez-Galindo, James Nicholson, Matthew J. Murray, Deborah F. Bilmire, Sara Stoneham...> ;Cancer. 2016 Jan 15
• 45 citations
  CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif
  Cheryl H Rozanski, Adam Utley, Louise M. Carlson, Matthew R. Farren, Megan Murray, Lisa Russell, Jayakumar R. Nair, ZhengYu Yang, William E. Brady, Lee Ann Garrett-Sin...> ;Journal of Immunology. 2015 May 15
• 34 citations
  A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fall...
  Lisa M. Landrum, William E. Brady, Deborah K. Armstrong, Kathleen N. Moore, Paul DiSilvestro, David M. O'Malley, Meaghan Tenney, Peter G. Rose, Paula M. Fracasso> ;Gynecologic Oncology. 2015 Apr 1
• 31 citations
  A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors
  Nuttapong Ngamphaiboon, Grace K. Dy, Wen Wee Ma, Yujie Zhao, Thanyanan Reungwetwattana, Dawn DePaolo, Yi Ding, William E. Brady, Gerald J. Fetterly, Alex A. Adjei> ;Investigational New Drugs. 2015 Feb 1
• Join now to see all